Clinical Trial Update: Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Erlotinib hydrochloride with or without carboplatin and paclitaxel in stage III-IV non-small cell lung cancer; completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Erlotinib hydrochloride (Erlotinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Adenocarcinoma, Lung Adenosquamous Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-04-23